|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 413/14 | |
| C07D 417/14 | |||
| C07D 419/14 | |||
| C07D 495/04 | |||
| A61K 31/422 | |||
| A61P 9/00 | |||
| A61P 11/00 |
| (11) | Number of the document | 3121177 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16162808.6 |
| Date of filing the European patent application | 2012-06-15 | |
| (97) | Date of publication of the European application | 2017-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161498110 P | 2011-06-17 | US |
| (72) |
BROOKS, Carl, US
CHEUNG, Mui, US
EIDAM, Hilary, Schenck, US
GOODMAN, Krista, B, US
HAMMOND, Marlys, US
HILFIKER, Mark, A, US
HOANG, Tram, H, US
PATTERSON, Jaclyn, R, US
STOY, Patrick, US
YE, Guosen, US
|
| (73) |
GlaxoSmithKline Intellectual Property (No. 2) Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | COMBINATIONS OF TRPV4 ANTAGONISTS |
| COMBINATIONS OF TRPV4 ANTAGONISTS |